Free Trial

JP Morgan Lead Mon's High-Grade Issuance

PIPELINE
$13.75B Priced Monday, JP Morgan outpaced UBS. Awaiting guidance from AstraZeneca investor calls
  • Date $MM Issuer (Priced *, Launch #)
  • 05/24 $4.5B *JP Morgan $2B 1NC3 +50, $500M 4NC3 FRN SOFR+53.5, $2B 8NC7 +80
  • 05/24 $3B *UBS $1B 2Y +28, $1B 2Y FRN SOFR+32, $1B 5Y +53
  • 05/24 $1.5B *Intesa Sanpaolo $750M 11NC10 +260, $750M 21NC20 +275
  • 05/24 $1.25B *Flex Intermediate Holdco $800M 10Y +175, $450M 18.5Y +210
  • 05/24 $1.25B *Bank of America 3NC2 +43
  • 05/24 $1B *Oklahoma Gas & Electric 2NC.5 +60a
  • 05/24 $750M *VeriSign 10Y
  • 05/24 $500M *Northwestern Mutual Global 7Y +45
  • 05/24 $Benchmark AstraZeneca EUR/USD multi-tranche investor calls (AstraZeneca issued $3B last year Aug 3: $1.2B +5Y +55, $1.3B 10Y +85, $500M 30Y +100)
  • 05/?? $Benchmark Pakistan WAPDA (Water and Power Dev Authority)

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.